B&N Buyout Bid Is a Bet Against Amazon, Apple

Liberty Media, the conglomerate controlled by John Malone, made a $1 billion bid Thursday to buy Barnes & Noble. The bricks-and-mortar bookstore business is declining everywhere, so for Malone's gamble is to pay off, the Nook will have to gain some ground against Apple's iPad and Amazon's Kindle.

M&A Mania: Early 2011 Deals Already Hit a 10-Year High

Companies such as Duke Energy and DuPont are off and running with megamergers early this year. Even Playboy is among the dealers. And market pros say the trend is far from over. Why are so many U.S. companies tying the knot? Fast growth is hard to come by in any other strategy.

Genzyme Talks Up Possible Sales of Its New MS Drug

Biotechnology company Genzyme is holding an analyst and investor meeting Monday focused on the commercial potential of its multiple sclerosis drug Campath as it tries to convince Sanofi-Aventis that it's worth more than the Paris-based pharmaceutical giant has been offering.

Report: AOL Preparing Possible Acquisition of Yahoo

AOL is reported to be collaborating with private equity firms to explore a possible Yahoo takeover attempt. In theory, an AOL-Yahoo deal would position the merged company to compete for online advertising dollars more effectively.

Sara Lee Shares Soar on Reports it Spurned KKR Offer

Food giant Sara Lee saw its shares surge over 18% in premarket trading Monday after the New York Post reported the company turned down a $12 billion buyout offer from private-equity company KKR & Co.), citing unnamed sources.

Sanofi Is in No Rush to Reach Deal With Genzyme

Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree on a deal, and he won't rush into anything.

Saks Shares Soar on Takeover Rumors

Saks shares have spiked on takeover speculation. Reports say a private equity consortium with U.S. and U.K. players is interested in buying the retailer and could offer some $1.7 billion for it.

Sanofi-Avenits Won't Boost Genzyme Bid

Pharmaceutical giant Sanofi-Aventis is unwilling to pay more than $70 a share in its bid to buy biotech firm Genzyme, media outlets reported Wednesday. If a deal can't be reached, the French drugmaker may consider alternative takeover targets.

Kuwait Fund Denies It Was Offered Chance to Raise BP Stake

Newspaper Al-Anba published a story saying BP's outgoing CEO Tony Hayward asked the Kuwait Investment Authority to up its stake to 3% to help protect the company from takeover bids. The authority says it received no such offer. Newspaper Al-Anba published a story saying that BP%u2019s outgoing CEO Tony Hayward asked Kuwait Investment Authority to up its stake to 3 % to help protect the company from takeover bids, Bloomberg News reported.

SSL, Maker of Durex Condoms, OKs $3.9 Billion Takeover Bid

SSL International Plc, the company which makes Durex condoms as well as Scholl foot care products, said its board is recommending a 2.54 billion pound ($3.9 billion) takeover offer from Reckitt Benckiser PLC. Reckitt Benckiser said the offer represents a 33% premium over SSL%u2019s July 20 share price, according to The Associated Press. The bid values the company at 1,163 pence a share plus a final dividend for last year of eight pence.

Abu Dhabi Considering Investing in BP, Crown Prince Says

Sheikh Mohammed bin Zayed Al Nahyan, crown prince of Abu Dhabi, says the emirate is considering investing in BP Plc (BP), Bloomberg News reported "We are still thinking about it," the crown prince told Bloomberg News when asked about buying a stake in the oil giant. "We have been partners with BP for years."

BP's Hayward in Middle East; Investment Rumors Fly

Embattled BP CEO Tony Hayward traveled to Abu Dhabi to meet business partners, with rumors flying that the company is seeking to raise funds to help the company pay for the clean up operation in the Gulf of Mexico. Hayward arrived in the Emirati capital on Tuesday and plans to stay "a couple of days", company spokesman Andrew Gowers told The Associated Press. Gowers declined to comment on whether or not Hayward would be meeting with investment funds.

Icahn's Next Move in the Lion's Gate Takeover Saga

What's the canny corporate raider's endgame strategy in his drawn-out pursuit of Lions Gate Entertainment? His current tender offer of $7 a share ends June 30. After that, the price could fall, making it cheaper for him to raise his stake.

Will Warren Buffett Take Over Goldman Sachs?

As Goldman Sachs gets tangled in more lawsuits and investigations, its situation is looking more and more like that of Salomon Brothers in 1991, when top executives resigned in disgrace and Warren Buffett took over. Could the billionaire investor be getting ready for a repeat performance?

Wendy's/Arby's Up on Possible Takeover

Nelson Peltz said Thursday he was approached by a third party about the possibility of participating in a takeover of Wendy's/Arby's. Peltz's Trian Fund Management LP, the biggest shareholder in the fast food chain with a 23.6% stake. In a regulatory filing, Trian said it is considering the inquiry and other alternatives, adding it is planning to discuss debt or equity financing with interested groups.

Why Carl Icahn Could Hike Hostile Bid for Lions Gate

With animosity now in the open between the activist investor and Lions Gate CEO and Co-Chairman Jon Feltheimer, Icahn appears only more furiously determined to win. But if he raises his offer, it likely won't be by too much.

VW is set to take over Porsche

It appears that the drawn-out struggle over the ownership of Porsche may be coming to an end. According to Saturday's edition of Der Spiegel,...